These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38108434)

  • 1. Elevated Lipoprotein(a) and Its Implications for Familial Hypercholesterolemia Diagnosis, Prognosis, and Family Screening.
    Santos RD
    J Clin Endocrinol Metab; 2024 Jun; 109(7):e1544-e1545. PubMed ID: 38108434
    [No Abstract]   [Full Text] [Related]  

  • 2. The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia.
    Yeang C; Willeit P; Tsimikas S
    Curr Opin Lipidol; 2020 Dec; 31(6):305-312. PubMed ID: 33027223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia.
    Afanasieva OI; Ezhov MV; Razova OA; Afanasieva MI; Utkina EA; Pokrovsky SN
    Atherosclerosis; 2018 Oct; 277():477-482. PubMed ID: 30270088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
    J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?
    Alonso R; Argüeso R; Álvarez-Baños P; Muñiz-Grijalvo O; Diaz-Diaz JL; Mata P
    Curr Atheroscler Rep; 2022 Jun; 24(6):427-434. PubMed ID: 35386090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
    Circulation; 2017 Aug; 136(9):880-882. PubMed ID: 28847800
    [No Abstract]   [Full Text] [Related]  

  • 7. Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family.
    Nikkola E; Ko A; Alvarez M; Cantor RM; Garske K; Kim E; Gee S; Rodriguez A; Muxel R; Matikainen N; Söderlund S; Motazacker MM; Borén J; Lamina C; Kronenberg F; Schneider WJ; Palotie A; Laakso M; Taskinen MR; Pajukanta P
    Atherosclerosis; 2017 Sep; 264():58-66. PubMed ID: 28772107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypercholesterolemia--epidemiology, diagnosis, and screening.
    Singh S; Bittner V
    Curr Atheroscler Rep; 2015; 17(2):482. PubMed ID: 25612857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cascade screening for familial hypercholesterolemia: Practical consequences.
    Louter L; Defesche J; Roeters van Lennep J
    Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or Assembly.
    Croyal M; Blanchard V; Ouguerram K; Chétiveaux M; Cabioch L; Moyon T; Billon-Crossouard S; Aguesse A; Bernardeau K; Le May C; Flet L; Lambert G; Hadjadj S; Cariou B; Krempf M; Nobécourt-Dupuy E
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):819-829. PubMed ID: 32078365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town.
    Huijgen R; Blom DJ; Hartgers ML; Chemello K; Benito-Vicente A; Uribe KB; Behardien Z; Blackhurst DM; Brice BC; Defesche JC; de Jong AG; Jooste RJ; Solomon GAE; Wolmarans KH; Hovingh GK; Martin C; Lambert G; Marais AD
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):934-943. PubMed ID: 33147992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia.
    Trinder M; DeCastro ML; Azizi H; Cermakova L; Jackson LM; Frohlich J; Mancini GBJ; Francis GA; Brunham LR
    J Am Coll Cardiol; 2020 Jun; 75(21):2682-2693. PubMed ID: 32466883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How can we improve the prognosis of patients with homozygous familial hypercholesterolemia?
    Harada-Shiba M
    Atherosclerosis; 2024 Jun; 393():117551. PubMed ID: 38658251
    [No Abstract]   [Full Text] [Related]  

  • 14. The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia.
    Cao YX; Liu HH; Sun D; Jin JL; Xu RX; Guo YL; Wu NQ; Zhu CG; Li S; Zhang Y; Sun J; Li JJ
    Atherosclerosis; 2018 Oct; 277():7-14. PubMed ID: 30170223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of Genetic Testing for Lipoprotein(a) Variants.
    Langsted A; Nordestgaard BG
    Circ Genom Precis Med; 2022 Apr; 15(2):e003737. PubMed ID: 35311528
    [No Abstract]   [Full Text] [Related]  

  • 16. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives.
    Wu MF; Xu KZ; Guo YG; Yu J; Wu Y; Lin LM
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):739-748. PubMed ID: 31655942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cascade screening for familial hypercholesterolemia from pediatric index cases diagnosed through universal screening.
    Lentz M; Benoy M; Zhang X; Peterson AL
    J Clin Lipidol; 2024; 18(4):e620-e624. PubMed ID: 38942689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When a "normal" cholesterol level is not normal: Exposing an unusual presentation of familial hypercholesterolemia.
    Orringer CE; Grant JK
    J Clin Lipidol; 2020; 14(4):414-418. PubMed ID: 32505727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.
    Alonso R; Mata P; Muñiz O; Fuentes-Jimenez F; Díaz JL; Zambón D; Tomás M; Martin C; Moyon T; Croyal M; Thedrez A; Lambert G
    Atherosclerosis; 2016 Nov; 254():249-253. PubMed ID: 27594539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.